Quantification of fibrin degradation products in glioma and meningioma patients

CAN, ÖZGE; Erdemgil, Yigit; Yildirim, Zeynep; ÖZDUMAN, KORAY; Pamir, Mustafa; Sav, Aydin; ÖZPINAR, AYSEL

doi:10.3233/cbm-140400

Quantification of fibrin degradation products in glioma and meningioma patients

CAN Ö., Erdemgil Y., Yildirim Z. Z., ÖZDUMAN K., Pamir M. N., Sav A., ...Daha Fazla

CANCER BIOMARKERS, cilt.14, sa.4, ss.253-258, 2014 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 14 Sayı: 4
Basım Tarihi: 2014
Doi Numarası: 10.3233/cbm-140400
Dergi Adı: CANCER BIOMARKERS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.253-258
Anahtar Kelimeler: Meningioma, glioma, fibrin degradation products, DR-70, DR-70(TM) IMMUNOASSAY, CANCER, CARCINOMA, SERUM, FDP
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

BACKGROUND: DR-70 is an immunoassay for fibrin and FDP in plasma and it has been shown useful in detection of over 14 different cancers. This study investigated the validity of the DR-70 test in gliomas as well as meningiomas.